Suficienca, Kai Leon A.
HRN: 22-63-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/04/2023
03/10/2023
IV
25mg
Q12
Infection
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes